Exact Sciences has expanded its collaboration with Humana to make the Cologuard Plus test available to eligible Humana Medicare Advantage members.

AI in the healthcare space has outpaced the rate of regulation, and without an update, HIPAA risks stifling innovation. The use of artificial intelligence (AI) and generative AI (GenAI) in the ...

Maui Imaging has secured $14m in a Series D financing round, including equity funding, for supporting CET-based imaging technology.

RFK Jr's statewide tour promoting his Make America Healthy Again (MAHA) agenda has been called “performative” by a US health consultancy.

Stryker has adjusted its 2025 profit outlook to between 9.5%-10%, up from 8.5%-9.5%, amid strong growth in its medical surgery and neurotechnology unit.

Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at certain breast cancer patients.

The FDA has approved SetPoint Medical’s neuroimmune modulation device, SetPoint System, to treat moderate-to-severe rheumatoid arthritis.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for CardioTag, Cardiosense’s multimodal, wearable sensor.

Medtronic's trial of INFUSE Bone Graft in the TLIF procedure for use in spine surgery achieved predefined early success criteria.

Axonius has acquired New York-headquartered healthcare cybersecurity firm Cynerio in a $100m cash and stock deal.

Johnson & Johnson MedTech has launched the VIRTUGUIDE System, an AI-powered Lapidus solution to minimise bunion surgery complexities.

The advent of artificial intelligence (AI) at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices.